Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Sales | 15,763,060 | 0 | 13,748,020 | 11,060,730 | 10,360,740 |
| Cost of Goods | 3,065,190 | N/A | 2,786,310 | 2,370,010 | 2,411,120 |
| Gross Profit | 12,697,870 | 12,742,780 | 10,961,710 | 8,690,720 | 7,949,610 |
| Operating Expenses | 8,179,650 | 4,622,910 | 6,730,790 | 4,805,130 | 4,506,910 |
| Operating Income | 4,518,409 | -4,622,910 | 4,231,229 | 3,885,601 | 3,442,830 |
| Interest Expense | 15,360 | 0 | 3,330 | 2,090 | 3,120 |
| Other Income | -31,769 | 0 | 1,540,521 | 1,416,309 | 987,270 |
| Pre-tax Income | 4,471,280 | -4,622,910 | 5,768,420 | 5,299,820 | 4,426,980 |
| Income Tax | 1,243,740 | N/A | 2,187,660 | 2,422,400 | 1,721,030 |
| Net Income Continuous | 3,209,680 | 2,343,850 | 3,120,886 | 2,874,491 | 2,772,254 |
| Net Income | $3,201,540 | $2,343,850 | $3,554,540 | $2,845,800 | $2,677,340 |
| EPS Basic Total Ops | 2.03 | 1.45 | 1.84 | 1.65 | 1.56 |
| EPS Basic Continuous Ops | 2.03 | 1.45 | 1.84 | 1.65 | 1.56 |
| EPS Diluted Total Ops | 2.03 | 1.45 | 1.84 | 1.65 | 1.56 |
| EPS Diluted Continuous Ops | 2.03 | 1.45 | 1.84 | 1.65 | 1.56 |
| EBITDA(a) | $5,753,079 | $-3,418,010 | $4,548,129 | $4,129,831 | $3,688,360 |